|
|
Article: Roche renews internal research license for patented gene targeting technology from Lexicon.(Roche Palo Alto LLC)(Lexicon Genetics Incorporated)(Brief Article)
- Article from:
- BIOTECH Patent News
- Article date:
- December 1, 2004
CopyrightCOPYRIGHT 2004 Biotech Patent News. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Lexicon Genetics Incorporated (The Woodlands, TX) announced that Roche Palo Alto LLC (Palo Alto, CA) has renewed its license agreement for non-exclusive rights under patents controlled by Lexicon covering gene targeting technologies for the generation of knockout mice. The renewed license will provide Roche with continued rights under patents covering the technologies frequently referred to as "isogenic DNA" and "positive-negative selection" to generate and use knockout mice in its internal drug discovery research. Financial terms of the agreement were not disclosed.
"We are pleased that Roche has elected to extend its access to our patented gene targeting ...
Related newspaper, magazine, and journal articles:
|
|
Article: Lexicon Genetics Discovers Target for Development ...
PR Newswire;
November 1, 2002 ;
700+ words
...Lexicon Genetics Incorporated announced today it ... president and chief executive officer of Lexicon Genetics. "Our discovery could lead to ... rash, diarrhea and bruising. Lexicon Genetics used its patented gene targeting ...
|
|